IMC Chicago’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
IMC Chicago's REGN Position: Q2 2026 in Review
IMC Chicago opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 5,591 shares worth $3.49M. The stake represents ﹤0.01% of the portfolio and ranks #2494 among its holdings. This is a return to the name: IMC Chicago previously reported a position in REGN as recently as Q2 2025.
IMC Chicago first reported a position in REGN in Q2 2025 and has held it in 2 quarters since. The position peaked at $9.42M in Q2 2025. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- IMC Chicago held 5,591 shares of Regeneron Pharmaceuticals worth $3.49M as of Q2 2026.
- Regeneron Pharmaceuticals was a new IMC Chicago position in Q2 2026.
- Regeneron Pharmaceuticals made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #2494 holding.
- IMC Chicago first reported a position in Regeneron Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
- IMC Chicago's Regeneron Pharmaceuticals position peaked at $9.42M in Q2 2025.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.